M. C. Sauerland

722 total citations
7 papers, 242 citations indexed

About

M. C. Sauerland is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, M. C. Sauerland has authored 7 papers receiving a total of 242 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 3 papers in Molecular Biology and 1 paper in Genetics. Recurrent topics in M. C. Sauerland's work include Acute Myeloid Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Cancer Genomics and Diagnostics (1 paper). M. C. Sauerland is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Cancer Genomics and Diagnostics (1 paper). M. C. Sauerland collaborates with scholars based in Germany, Australia and United States. M. C. Sauerland's co-authors include Thomas Büchner, Torsten Haferlach, Eva Lengfelder, Dagmar Haase, Claudia Schoch, C. Fonatsch, Mathias Freund, H. Wandt, Hartmut Link and H. Löffler and has published in prestigious journals such as Leukemia, Haematologica and Annals of Hematology.

In The Last Decade

M. C. Sauerland

5 papers receiving 236 citations

Peers

M. C. Sauerland

HEMAT

MB

PHEOH

GENET

CR

F. del Valle Germany

S. Brunet Mauri United Kingdom

Gudrun Mellert Germany

S-J Wu Taiwan

J. Th. Fischer Germany

J. Krauter Germany

Torsten Haferlach Germany

Hans‐Joachim Tischler Germany

Kiran Tawana United Kingdom

Andrew J. Menssen United States

F. del Valle Germany

M. C. Sauerland

261 ×1.2

HEMAT

145 ×1.2

MB

102 ×1.4

PHEOH

58 ×0.9

GENET

14 ×0.6

CR

Citations per year, relative to M. C. Sauerland M. C. Sauerland (= 1×) peers F. del Valle

Countries citing papers authored by M. C. Sauerland

Since Specialization

Citations

This map shows the geographic impact of M. C. Sauerland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. C. Sauerland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. C. Sauerland more than expected).

Fields of papers citing papers by M. C. Sauerland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. C. Sauerland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. C. Sauerland. The network helps show where M. C. Sauerland may publish in the future.

Co-authorship network of co-authors of M. C. Sauerland

This figure shows the co-authorship network connecting the top 25 collaborators of M. C. Sauerland. A scholar is included among the top collaborators of M. C. Sauerland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. C. Sauerland. M. C. Sauerland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Rothenberg‐Thurley, Maja, Susanne Amler, Dennis Göerlich, et al.. (2016). Persistence of Driver Mutations during Complete Remission Associates with Shorter Survival and Contributes to the Inferior Outcomes of Elderly Patients with Acute Myeloid Leukemia. Haematologica. 2 indexed citations

2.

Köhnke, Thomas, Eva Hoster, M. Hubmann, et al.. (2014). Early assessment of minimal residual disease in AML by flow cytometry during aplasia identifies patients at increased risk of relapse. Leukemia. 29(2). 377–386. 50 indexed citations

3.

Greif, Philipp A., Nikola P. Konstandin, Klaus H. Metzeler, et al.. (2012). RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes. Haematologica. 97(12). 1909–1915. 66 indexed citations

4.

Schoch, Claudia, Dagmar Haase, Torsten Haferlach, et al.. (1996). Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor.. PubMed. 10(8). 1288–95. 102 indexed citations

5.

Haferlach, Torsten, W. Gaßmann, H. Löffler, et al.. (1993). Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo. Annals of Hematology. 66(4). 165–170. 22 indexed citations

6.

Heinecke, Achim, M. C. Sauerland, & Th. Büchner. (1990). Predictive Models for Achievement of Complete Remission and Duration of First Remission in Adult Acute Myeloid Leukemia. Hämatologie und Bluttransfusion. 33. 285–289.

7.

Heinecke, Achim, M. C. Sauerland, & Th. Büchner. (1990). Sequential Decision Strategy of the AML Cooperative Group Studies. Hämatologie und Bluttransfusion. 33. 290–294.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact